Skip to content

Quebec Lung Cancer Screening PLUS Trial

COPD | Coronary Artery Calcification

Does an educational intervention for untreated COPD and cardiovascular disease which is integrated in an existing lung cancer screening program improve guideline concordant medication adherence at 12 months

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    55 to 74

Critères de participation

Inclusion Criteria:

* Patient screened for lung cancer as part of the Quebec Lung Cancer Demonstration project by low dose CT scan of the chest.
* Cardiovascular aim: mild to severe CAC identified on low dose CT, not on guideline recommended lipid-lowering therapy.
* COPD aim: diagnosed with COPD, symptomatic (mMRC \>=1 or CAT\>= 10) and untreated, or not on first line guideline recommended therapy for COPD.

Exclusion Criteria:

* Any participant with a high suspicion of lung cancer, defined as Lung-RADS (Lung Imaging Reporting and Data System) 3 or 4, as this is an inopportune time to initiate new medical therapies.
* Cardiovascular aim: Absent CAC, known clinical atherosclerosis, known former heart surgery, Diabetes Mellitus.
* COPD aim: asymptomatic, or already on appropriate first line COPD therapy.

Lieu de l'étude

McGill University Health Center
McGill University Health Center
Montreal, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Nicole Ezer, MD MPH

[email protected]
5149341934
Backup Contact

Charlotte Besson, PHD

[email protected]
4508484141
Étude parrainée par
McGill University Health Centre/Research Institute of the McGill University Health Centre
Participants recherchés
Plus d'informations
ID de l'étude: NCT05444062